STING1 and neoplasm: In a word, our findings confirmed that RT activated the cGAS‐STING pathway, triggered type I IFN response, induced ICD in tumor cells, and upregulated tumor cell surface MHC‐I, thus priming anti‐tumor immunity and restoring immune recognition.